Close Search
Kinesin Spindle Protein: An Anticancer Drug Target
Close Search
mask-group
Events

11 Oct 2022

Kinesin Spindle Protein: An Anticancer Drug Target

The Department of Biotechnology, School of Applied Sciences organized a Guest talk on “Kinesin Spindle Protein: An anti-cancer Target” on 11/10/2022. The resource person for the talk was Dr. Rajasekhar Karpoormath, Associate Professor, Department of Pharmaceutical Chemistry, School of Health Sciences, University of Kwazulu-Natal, Durban, South Africa. He has more than two decades of experience in teaching and Research. His Main area of Research is Target based drug design and synthesis of small molecules as potential anticancer and antimicrobial agents. Till date he has published 149 papers, two book chapters and two patents, just in a span of 7 years (2014-2021) in international journals. Over the years he has successfully secured several national and institutional grants worth over 6.5 million Rand (500,000 USD), He established a well-equipped Drug Discovery Laboratory. He has successfully graduated 21 postgraduate students (17 Ph.Ds. and 15 Masters) since 2014. He is one of the top researchers at UKZN and was the recipient of several awards in recognition of his achievements. The talk was conducted offline in Dr. APJ Abdul Kalam seminar Hall, SoAS block. 78 postgraduate students from Biotechnology and B.Sc Bioinformatics attended the session.

Dr. Rajasekhar Karpoormath began his presentation by discussing the development of innovative medications through in silico research. He has also discussed the importance of finding new medicinal medications to cure diseases like cancer. He also discussed South Africa's potential for academic and research advancement. Additionally, he had provided information about funding and fellowship prospects abroad. The overall session was quite participatory, and Dr. Rajasekhar Karpoormath gave the students a lot of advices regarding higher studies and student exchange programme with South Africa.

cafeteria
cafeteria
cafeteria
Kinesin Spindle Protein: An Anticancer Drug Target
close

Notifications

banner-icon